Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
25.49
+0.93 (3.79%)
At close: Aug 19, 2026, 4:00 PM EDT
25.99
+0.50 (1.96%)
After-hours: Aug 19, 2026, 7:43 PM EDT

Adaptive Biotechnologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,0682,4798857091,0933,960
Market Cap Growth
104.87%180.23%24.72%-35.07%-72.41%-51.03%
Enterprise Value
4,1072,4768425697983,441
Last Close Price
25.4916.246.004.907.6428.06
PS Ratio
13.208.954.944.175.9025.66
PB Ratio
28.3711.024.372.302.356.56
P/TBV Ratio
176.4325.2711.023.853.238.31
EV/Sales Ratio
13.338.944.703.344.3122.29
Debt / Equity Ratio
2.730.941.100.740.500.19
Net Debt / Equity Ratio
0.26-0.13-0.16-0.38-0.57-0.76
Net Debt / EBITDA Ratio
-1.820.760.250.651.482.35
Net Debt / FCF Ratio
-1.610.610.340.701.321.80
Asset Turnover
0.540.530.300.220.210.15
Inventory Turnover
17.3018.0915.3013.6811.8411.50
Quick Ratio
4.513.102.714.384.913.27
Current Ratio
4.803.342.894.665.123.54
Return on Equity (ROE)
-38.76%-27.82%-62.49%-58.34%-37.52%-30.77%
Return on Assets (ROA)
-4.12%-6.79%-16.18%-16.60%-14.06%-12.81%
Return on Capital Employed (ROCE)
-6.80%-13.50%-35.20%-35.20%-26.80%-25.80%
Earnings Yield
-1.57%-2.40%-18.03%-31.75%-18.32%-5.23%
FCF Yield
-0.59%-1.97%-11.18%-23.54%-18.33%-6.43%
Buyback Yield / Dilution
-4.11%-3.14%-1.88%-1.31%-1.54%-6.96%
SEC Filings: 10-K · 10-Q